$SNY $MRK $NVO $LLY: Novo Nordisk’s Victoza Gets FDA Nod for Pediatric Patients

Date: Tuesday, June 18th, 2019

Stock(s) mentioned: , , ,

Source: Zacks.com (https://www.zacks.com)

Summary: Novo Nordisk’s (NVO) Victoza gets FDA approval for the treatment of pediatric patients aged 10 years or older with type II diabetes.

Full article address: https://www.zacks.com/stock/news/431041/Novo-Nordisks-Victoza-Gets-FDA-Nod-for-Pediatric-Patients

Related News:

$MRK $GILD $ALXN $GLPG: Will Strong HIV Sales Drive Gilead’s (GILD) Q3 Earnings?

$PFE $MRK $NVS $GILD: Factors Setting the Tone for Novartis’ (NVS) Q3 Earnings

$MRK: Merck Receives EU CHMP Positive Opinion for Investigational V920 …

$MRK $BA $AAPL $UTX $PG: 5 Dow Stocks Poised to Beat on Earnings This Month

$MRK: (pembrolizumab) as First-Line Treatment for Metastatic or …

$MRK: Merck to eliminate 500 jobs

$PFE $NVS $MRK: AcelRx Pharmaceuticals: Extremely Promising Risk/Reward Profile

$ABBV $MRK $JNJ $TEVA: J&J (JNJ) Beats on Q3 Earnings as Sales Rise, Ups 2019 View

$AGN $MRK: FDA OKs Hisamitsu Pharma’s asenapine patch for schizophrenia

$MRK: Better Buy: GlaxoSmithKline vs. Merck

$PFE $MRK $LLY: 3 Dividend-Paying Pharma Stocks to Buy Now

Latest News:

$VRTX: (tezacaftor/ivacaftor and ivacaftor) for Eligible Patients Ages 12 and …

$EYE $GS $KKR $WMT: Watch out, National Vision bulls: The outlook is growing ever dimmer for eyeglass seller

$DJIA: Baby boomers commit the ‘7 deadly sins’ of retirement planning

$JPM $SAN $LYG $BCS $BAC: Stricter regulations for banks have made their preferred stocks even more attractive, says Pimco’s Philippe Bodereau

$BX $PTON $WE $UBER $LYFT: Market Extra: Blackstone’s billionaire co-founder says investors should worry about these 5 market dilemmas

$BA $LUV: The maker of the 737 MAX faces three key tests over the next few weeks that could break the stock out of its holding pattern

$EXPGY: What Is a Credit Reference? Definition and Example

$TWTR $KO $AAPL $GOOGL: Meet the millennial who’s sworn off her smartphone for 12 months for $100,000 — and why she won’t go back to one

$EURUSD $GBPUSD: Parliament vote forces UK to postpone Brexit beyond Oct. 31

$HEP: This Dividend Growth Streak Comes to an End After 59 Consecutive …

$AMRN $HRTX: 2 Stocks That Could Double Your Money in 2020